biote Corp. (BTMD)
3.46
-0.17 (-4.68%)
At close: Apr 02, 2025, 3:59 PM
3.55
2.66%
After-hours: Apr 02, 2025, 07:30 PM EDT
Company Description
biote Corp. operates in medical practice-building business within the hormone optimization space.
The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women.
The company was founded in 2011 and is headquartered in Irvine, Texas.
biote Corp.
| Country | United States |
| IPO Date | Apr 28, 2021 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 217 |
| CEO | Bret Christensen |
Contact Details
Address: 1875 West Walnut Hill Lane Irving, Texas United States | |
| Website | https://biote.com |
Stock Details
| Ticker Symbol | BTMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819253 |
| CUSIP Number | 090683103 |
| ISIN Number | US0906831039 |
| Employer ID | 85-1791125 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Bret Christensen | Chief Executive Officer & Director |
| James Elliott Gibbs II | Chief People Officer |
| Joel Pickering | Chief Marketing Officer |
| John J. Olsen | Chief Information Officer |
| Robert C. Peterson | Chief Financial Officer |
| Dr. Cory Rice D.O. | Chief Clinical Advisor & Member of Medical Advisory Board |
| Jade Beutler | Head of Nutraceuticals |
| Marc D. Beer | Executive Chairman |
| Mary Elizabeth Conlon | Vice President of Business Development, General Counsel & Corporate Secretary |
| Richard Kevin Key | Chief Digital Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 19, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Mar 17, 2025 | 4 | Filing |
| Mar 17, 2025 | 8-K | Current Report |
| Mar 14, 2025 | 10-K | Annual Report |
| Mar 12, 2025 | 8-K | Current Report |
| Mar 03, 2025 | 4 | Filing |